Fibromyalgia syndrome

Fibromyalgia, a chronic and debilitating condition, affects approximately 2-4% of the population, disproportionately affecting women with a ratio of 9 to 1 compared to men. While its exact cause remains unclear, it is believed to involve central nervous system sensitization leading to abnormal brain function.

Recent studies suggest that hyperbaric therapy can significantly enhance the quality of life for individuals with fibromyalgia. By promoting neuroplasticity, this therapy has the potential to normalize brain function and alleviate the painful symptoms associated with the condition.



Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography
Building up the pressure on chronic pain
Hyperbaric oxygen treatment decreases inflammation and mechanical hypersensitivity in an animal model of inflammatory pain